Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | STS | P08842 | 5/20 | 0.38 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4544962 | 0.76 | PLA2G2D (0.40) | ALDH1A1NPC1MAPTRAB9ATSHR | |
| SCHEMBL4544967 | 0.76 | ALDH1A1 (0.40) | ALDH1A1NPC1MAPTRAB9ATSHR | |
| SCHEMBL9360090 | 0.69 | ALDH1A1 (0.48) | ALDH1A1NPC1MAPTRAB9ATSHR | |
| SCHEMBL9360086 | 0.69 | ALDH1A1 (0.48) | ALDH1A1NPC1MAPTRAB9ATSHR | |
| SCHEMBL27566040 | 0.69 | LMNA (0.50) | ALDH1A1MAPTTSHRLMNATP53 | |
| SCHEMBL28093685 | 0.69 | LMNA (0.50) | ALDH1A1NPC1MAPTRAB9ATSHR | |
| SCHEMBL9359884 | 0.68 | LMNA (0.49) | ALDH1A1NPC1MAPTRAB9ATSHR | |
| SCHEMBL9359888 | 0.68 | LMNA (0.49) | ALDH1A1NPC1MAPTRAB9ATSHR | |
| SCHEMBL7570462 | 0.67 | NAAA (0.55) | ALDH1A1TSHRLMNANAAA | |
| SCHEMBL28550892 | 0.67 | ALDH1A1 (0.48) | ALDH1A1NPC1MAPTRAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8298736-B2 | Electrophotographic toner | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2012-10-30 | — | — | US | disclosed |
| US-8178267-B2 | Electrophotographic toner | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2012-05-15 | — | — | US | disclosed |
| US-20090291377-A1 | ELECTROPHOTOGRAPHIC TONER | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2009-11-26 | — | — | US | disclosed |
| US-20090291381-A1 | ELECTROPHOTOGRAPHIC TONER | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2009-11-26 | — | — | US | disclosed |
| US-20090233207-A1 | PYRAZOLOTRIAZOLE COMPOUND AND ELECTROPHOTOGRAPHIC TONER | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233207-A1 | PYRAZOLOTRIAZOLE COMPOUND AND ELECTROPHOTOGRAPHIC TONER | HAX1, XDH, GLRX3 | ALDH1A1 3741/4885NPC1 4186/4885MAPT 4455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.